美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Reviva Pharmaceuticals Holdings, Inc. Warrant 2025/12/25 11.5C

0.0030

0.0000

成交量：- -

成交額：- -

市值：20.40萬

市盈率：-0.01

高：0.0030

開：0.0030

低：0.0030

收：0.0030

52周最高：0.1760

52周最低：0.0030

股本：6,800.36萬

流通股本：6,800.36萬

量比：- -

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):-0.4722

淨資產收益率：-53.85%

總資產收益率：-23.19%

市淨率：0.01

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

Reviva Pharmaceuticals Holdings, Inc. Warrant 2025/12/25 11.5C

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://www.revivapharma.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

Reviva Pharmaceuticals Holdings, Inc.於2018年3月20日在英屬維爾京群島註冊成立。該公司是一家後期製藥公司，致力於發現、開發並尋求將下一代治療方法商業化，以治療那些對社會、患者及其家庭具有重大未滿足醫療需求和負擔的疾病。他們目前的產品線主要集中在中樞神經系統、炎症和心臟代謝疾病。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/RVPHW/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RVPHW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RVPHW\",,,,,undefined,":{"symbol":"RVPHW","market":"US","secType":"WAR","nameCN":"Reviva Pharmaceuticals Holdings, Inc. Warrant 2025/12/25 11.5C","latestPrice":0.003,"timestamp":1771948913985,"preClose":0.003,"halted":0,"volume":0,"delay":0,"changeRate":0,"strike":11.5,"lastTradingDate":1766638800000,"nameEN":"Reviva Pharmaceuticals Holdings, Inc. Warrant 2025/12/25 11.5C","floatShares":68003616,"shares":68003616,"eps":-0.4722,"marketStatus":"交易中","change":0,"latestTime":"02-24 11:01:53 EST","open":0.003,"high":0.003,"low":0.003,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.4722,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1771966800000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":0.003,"volumeRatio":0,"lotSize":1,"type":1,"expireDate":1766638800000,"ul":"RVPH","ulStockBrief":{"symbol":"RVPH","market":"US","secType":"STK","nameCN":"Reviva Pharmaceuticals Holdings, Inc.","latestPrice":0.2327,"timestamp":1771948913820,"preClose":0.24,"halted":0,"volume":950075,"delay":0}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RVPHW\",,,,,undefined,":{"symbol":"RVPHW","floatShares":68003616,"roa":"-23.19%","roe":"-53.85%","lyrEps":0,"shares":68003616,"dividePrice":0,"high":0.003,"amplitude":0,"preClose":0.003,"low":0.003,"week52Low":0.003,"pbRate":"0.01","week52High":0.176,"institutionHeld":0,"latestPrice":0.003,"eps":-0.4722,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.4722,"open":0.003,"prevYearClose":0.003,"prevWeekClose":0.003,"prevMonthClose":0.003,"prevQuarterClose":0.003,"fiveDayClose":0.003,"twentyDayClose":0.003,"sixtyDayClose":0.0116},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RVPHW\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RVPHW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RVPHW\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.revivapharma.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":-0.7414},{"period":"6month","weight":-0.9538},{"period":"1year","weight":-0.9752},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0009},{"period":"1month","weight":-0.0099},{"period":"3month","weight":0.0109},{"period":"6month","weight":0.0553},{"period":"1year","weight":0.1374},{"period":"ytd","weight":0.0007}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Reviva Pharmaceuticals Holdings, Inc.於2018年3月20日在英屬維爾京群島註冊成立。該公司是一家後期製藥公司，致力於發現、開發並尋求將下一代治療方法商業化，以治療那些對社會、患者及其家庭具有重大未滿足醫療需求和負擔的疾病。他們目前的產品線主要集中在中樞神經系統、炎症和心臟代謝疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.177713},{"month":2,"riseRate":0.5,"avgChangeRate":-0.00728},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.216573},{"month":4,"riseRate":0.571429,"avgChangeRate":0.104507},{"month":5,"riseRate":0.571429,"avgChangeRate":0.190476},{"month":6,"riseRate":0.428571,"avgChangeRate":0.096492},{"month":7,"riseRate":0,"avgChangeRate":-0.226702},{"month":8,"riseRate":0.571429,"avgChangeRate":0.282004},{"month":9,"riseRate":0.857143,"avgChangeRate":0.145119},{"month":10,"riseRate":0.142857,"avgChangeRate":0.105775},{"month":11,"riseRate":0.5,"avgChangeRate":0.197242},{"month":12,"riseRate":0.5,"avgChangeRate":-0.011169}],"exchange":"NASDAQ","name":"Reviva Pharmaceuticals Holdings, Inc. Warrant 2025/12/25 11.5C","nameEN":"Reviva Pharmaceuticals Holdings, Inc. Warrant 2025/12/25 11.5C"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"RVPHW\",market:\"US\",,,undefined,":null}}